Maralixibat chloride, sold under the brand name Livmarli, is a medication used to treat cholestatic pruritus in people with Alagille syndrome. Maralixibat chloride is an ileal bile acid transporter (IBAT) inhibitor. Maralixibat was approved for medical use in the United States in September 2021.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:alternativeName |
|
| dbo:casNumber |
|
| dbo:chEMBL |
|
| dbo:class | |
| dbo:drugbank |
|
| dbo:fdaUniiCode |
|
| dbo:kegg |
|
| dbo:thumbnail | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink |
|
| dbp:atcPrefix |
|
| dbp:atcSuffix |
|
| dbp:c |
|
| dbp:casNumber |
|
| dbp:chembl |
|
| dbp:chemspiderid |
|
| dbp:cl |
|
| dbp:class |
|
| dbp:dailymedid |
|
| dbp:drugbank |
|
| dbp:h |
|
| dbp:index2Label |
|
| dbp:iupacName |
|
| dbp:kegg |
|
| dbp:legalUs |
|
| dbp:n |
|
| dbp:o |
|
| dbp:routesOfAdministration | |
| dbp:s |
|
| dbp:smiles |
|
| dbp:stdinchi |
|
| dbp:stdinchikey |
|
| dbp:synonyms |
|
| dbp:tradename |
|
| dbp:unii |
|
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |
